# Intravenous Plasma Treatment for Parkinson's Disease

> **NCT04202757** · EARLY_PHASE1 · COMPLETED · sponsor: **The Neurology Center** · enrollment: 22 (actual)

## Conditions studied

- Idiopathic Parkinson Disease

## Interventions

- **BIOLOGICAL:** [21CFR640.30] Plasma from 18 - 25 year old volunteer donors
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT04202757
- **Lead sponsor:** The Neurology Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-24
- **Primary completion:** 2019-08-07
- **Final completion:** 2019-08-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04202757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04202757, "Intravenous Plasma Treatment for Parkinson's Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04202757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*